CTM01 is a murine-derived IgG1 (or humanized IgG4) monoclonal antibody inhibitor targeting MUC1. It exhibits broad-spectrum anticancer activity against epithelial-derived solid tumors such as breast cancer, lung cancer, and ovarian cancer.
Target:
Mucin
* VAT and and shipping costs not included. Errors and price changes excepted